A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib (E7080/MK-7902) with Pembrolizumab (MK-3475) in Combination with Transarterial Chemoembolization (TACE) Versus TACE in Participants with Incurable/Non-metastatic Hepatocellular Carcinoma (LEAP-012).

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • Lewis, Paula (Project Manager)

Project: Research

Project Details

Effective start/end date5/06/2031/12/23


  • Gastroenterology
  • Hepatocellular carcinoma
  • Clinical trial